NF-449
NF-449
NF-449 is a chemical compound known for its role as a selective antagonist of the P2X1 receptor, a subtype of the P2X receptor family. These receptors are ligand-gated ion channels that are activated by the binding of extracellular adenosine triphosphate (ATP). NF-449 is particularly noted for its high selectivity towards the P2X1 receptor, making it a valuable tool in the study of purinergic signaling.
Chemical Structure and Properties
NF-449 is a suramin analogue, characterized by its complex structure that includes multiple sulfonate groups. The presence of these groups is crucial for its interaction with the P2X1 receptor, contributing to its high affinity and selectivity.
Molecular Formula
The molecular formula of NF-449 is C28H24N6O8S6.
Molecular Weight
The molecular weight of NF-449 is approximately 740.88 g/mol.
Mechanism of Action
NF-449 functions as a competitive antagonist at the P2X1 receptor. By binding to the receptor, it prevents the action of ATP, thereby inhibiting the receptor's ion channel activity. This blockade of the P2X1 receptor can modulate various physiological processes, including platelet aggregation, smooth muscle contraction, and neurotransmission.
Applications in Research
Due to its specificity, NF-449 is widely used in research to study the physiological and pathological roles of P2X1 receptors. It has been instrumental in elucidating the role of these receptors in cardiovascular function, pain perception, and immune responses.
Cardiovascular Research
In cardiovascular studies, NF-449 has been used to investigate the role of P2X1 receptors in vasoconstriction and blood pressure regulation.
Pain and Sensory Research
NF-449 has also been employed in studies exploring the involvement of P2X1 receptors in nociception and sensory neuron signaling.
Safety and Handling
As with many research chemicals, NF-449 should be handled with care. Appropriate safety measures, including the use of personal protective equipment, should be employed when working with this compound.
Also see
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD